| Journal | Journal of biotechnology and biomedicine |
| Study Type | Randomized Trial |
| Population | Human participants |
Muscular dystrophy patients face progressive muscle degeneration with limited pharmaceutical options, making evidence-based non-pharmacologic interventions critical for clinical decision-making. This systematic review directly compares established exercise therapy with emerging cannabidiol supplementation, providing clinicians with comparative efficacy data for muscle preservation strategies.
This systematic review compared exercise therapy versus cannabidiol supplementation for muscle preservation in muscular dystrophy patients. Exercise interventions (aerobic, resistance, functional training) showed consistent modest benefits in functional performance, endurance, and quality of life with acceptable safety profiles when individualized. The cannabidiol evidence appears incomplete in the provided abstract, suggesting limited clinical data compared to the more robust exercise literature. The review addresses a critical clinical gap given the absence of curative pharmacologic therapies for this progressive neuromuscular condition.
“While I appreciate systematic attempts to evaluate CBD for neuromuscular conditions, the established exercise therapy literature far outweighs any cannabidiol evidence for muscular dystrophy. Without seeing completed CBD data from this review, I remain focused on evidence-based exercise prescriptions for these patients.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- Should exercise therapy be recommended for patients with muscular dystrophy?
- Is CBD supplementation currently recommended for muscular dystrophy patients?
- What types of exercise are most beneficial for muscular dystrophy patients?
- Are there any safety concerns with exercise therapy in muscular dystrophy?
- What are the main outcomes improved by exercise in muscular dystrophy patients?
FAQ
Should exercise therapy be recommended for patients with muscular dystrophy?
Yes, exercise interventions including aerobic, resistance, and functional training demonstrate modest but consistent benefits in functional performance, endurance, and quality of life. When appropriately individualized, these interventions have acceptable safety profiles and represent an established cornerstone of conservative management.
Is CBD supplementation currently recommended for muscular dystrophy patients?
CBD supplementation is not currently recommended for routine clinical use in muscular dystrophy, as evidence is primarily limited to preclinical studies. More robust clinical trials are needed to establish safety and efficacy in human patients before clinical implementation.
What types of exercise are most beneficial for muscular dystrophy patients?
The systematic review found that aerobic exercise, resistance training, and functional training all provide benefits when properly individualized. The key is appropriate customization based on the patient’s specific type of muscular dystrophy, disease stage, and functional capacity.
Are there any safety concerns with exercise therapy in muscular dystrophy?
Exercise therapy demonstrates acceptable safety profiles when appropriately individualized for each patient. Proper assessment and customization based on disease severity and functional status are essential to maximize benefits while minimizing potential risks.
What are the main outcomes improved by exercise in muscular dystrophy patients?
Exercise interventions consistently improve functional performance, endurance capacity, and quality of life measures. While the benefits are described as modest, they are consistent across different types of exercise interventions when properly implemented.
